Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A community you can count on Join the thousands of people who have said yes to real support Check your eligibility in under 2 minutes Own your wellness with personalized GLP-1 care 125 k OrderlyMeds customers that reported weight loss with us * 1M + Total pounds lost by OrderlyMeds customers * 15 lbs Average weight loss on our 3-month starter plan * *Based on OrderlyMeds customer data collected from January 1, 2024 October 31, 2025
The global GLP-1 targeted peptide weight loss drugs market size was calculated at USD 61.18 billion in 2024 and is expected to reach USD 193.44 billion by 2034, expanding at a CAGR of 12.2% between 2025 and 2034
Obesity is linked to a wide range of health conditions, including heart disease, diabetes, cancer, and stroke
Tirzepatide: Currently FDA-approved for type 2 diabetes (Mounjaro) and under review for weight-loss indications
US$ 20.76
US$ 22.11
US$ 23.61
US$ 27.19
